In vitro effects of vitamin supplements on platelet-activating factor and its metabolism in age-related macular degeneration

References

• Tsantila N, Tsoupras AB, Fragopoulou E, et al. In vitro and in vivo effects of statins on platelet-activating factor and its metabolism. Angiology 2011;62:209–218
   PubMed Web of Science ®Google Scholar
• Tsoupras AB, Roulia M, Ferentinos E, et al. Structurally diverse metal coordination compounds, bearing imidodiphosphinate and diphosphinoamine ligands, as potential inhibitors of the platelet activating factor. Bioinorg Chem Appl 2010;pii:731202
   Google Scholar
• Sharif NA, Xu S, Hellberg PE, et al. Human conjunctival epithelial cell responses to platelet-activating factor (PAF): signal transduction and release of proinflammatory cytokines. Mol Vis 2009;15:1153–1161
   PubMed Web of Science ®Google Scholar
• Prescott SM, Zimmerman GA, McIntyre TM. Platelet-activating factor. J Biol Chem 1996;268:17381–17384
   Google Scholar
• Camussi G, Montrucchio G, Lupia E, et al. Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet activating factor synthesis from macrophages. J Immunol 1997;158:1302–1309
   PubMed Web of Science ®Google Scholar
• Montrucchio G, Lupia E, Battaglia E, et al. Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model. Arterioscler Thromb Vasc Biol 2000;20:80–88
   PubMed Web of Science ®Google Scholar
• Montrucchio G, Lupia E, Battaglia E, et al. Tumor-necrosis factor a-induced angiogenesis depends on in situ platelet activating factor biosynthesis. J Exp Med 1994;180:377–382
   PubMed Web of Science ®Google Scholar
• Camussi G, Montrucchio G, Lupia E, et al. Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism. J Immunol 1995;154:6492–6501
   PubMed Web of Science ®Google Scholar
• Bazan HE, Tao Y, Hurst JS. Platelet-activating factor antagonists and ocular inflammation. J Ocul Pharmacol 1994;10:319–327
   PubMedGoogle Scholar
• Proud D, Sweet J, Stein P, et al. Inflammatory mediator release on conjunctival provocation of allergic subjects with allergen. J Allergy Clin Immunol 1990;85:896–905
   PubMed Web of Science ®Google Scholar
• Verbey NL, Van Delft JL, Van Haeringen NJ, Braquet P. Platelet-activating factor and laser trauma of the iris. Invest Ophthalmol Vis Sci 1989;30:1101–1103
   PubMed Web of Science ®Google Scholar
• Sheng Y, Berkle DL. Intracamerally injected platelet activating factor (PAF) induces marked intraocular inflammatory reactions. Curr Eye Res 1992;11:1067–1078
   PubMed Web of Science ®Google Scholar
• Mori M, Aihara M, Shimizu T. Localization of platelet activating factor receptor messenger RNA in the rat eye. Invest Ophthalmol Vis Sci 1997;38:2672–2678
   PubMed Web of Science ®Google Scholar
• Beauchamp MH, Marrache AM, Hou X, et al. Platelet-activating factor in vasoobliteration of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 2002;43:3327–3337
   PubMed Web of Science ®Google Scholar
• Esquenazi S, Bazan HE. Role of platelet-activating factor in cell death signaling in the cornea: a review. Mol Neurobiol 2010;42:32–38
   PubMed Web of Science ®Google Scholar
• Smith D, Lee EK, Saloupis P, et al. Role of neutrophils in breakdown of the blood-retinal barrier following intravitreal injection of platelet-activating factor. Exp Eye Res 1994;59:425–432
   PubMed Web of Science ®Google Scholar
• Stafforini DM, McIntyre TM, Zimmerman GA, Prescott SM. Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes. Crit Rev Clin Lab Sci 2003;40:643–672
   PubMed Web of Science ®Google Scholar
• Negro Alvarez JM, Miralles López JC, Ortiz Martínez JL, et al. Platelet-activating factor antagonists. Allergol Immunopathol 1997;25:249–258
   PubMedGoogle Scholar
• Johnson EJ. Age-related macular degeneration and antioxidant vitamins: recent findings. Curr Opin Clin Nutr Metab Care 2010;13:28–33
   PubMed Web of Science ®Google Scholar
• Tsoupras AB, Chini M, Mangafas N, et al. Platelet-activating factor and its basic metabolic enzymes in blood of naive HIV-infected patients. Angiology 2012;63:343--352
   Google Scholar
• Bradford MM. A rapid and sensitive method for the quantization of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–254
   PubMed Web of Science ®Google Scholar
• Demopoulos CA, Pinckard RN, Hanahan DJ. Platelet-activating factor—evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J Biol Chem 1979;254:9355–9358
   PubMed Web of Science ®Google Scholar
• Antonopoulou S, Fragopoulou E, Karantonis HC, et al. Effect of traditional Greek Mediterranean meals on platelet aggregation in normal subjects and in patients with type 2 diabetes mellitus. J Med Food 2006;9:356–362
   PubMed Web of Science ®Google Scholar
• Tsoupras AB, Fragopoulou E, Nomikos T, et al. Characterization of the de novo biosynthetic enzyme of platelet activating factor, DDT insensitive cholinephosphotransferase, of human mesangial cells. Mediators Inflamm 2007;2007:27683
   PubMed Web of Science ®Google Scholar
• Tsoupras AB, Chini M, Tsogas N, et al. Anti-platelet activating factor effects of highly active antiretroviral therapy (HAART): a new insight in the drug therapy of HIV infection? AIDS Res Hum Retroviruses 2008;24:1079–1086
   PubMed Web of Science ®Google Scholar
• Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911–917
   PubMedGoogle Scholar
• Gimenez R, Aguilar J. Cytidine (5-) diphosphocholine induced decrease in cerebral platelet activating factor is due to inactivation of its synthesizing enzyme cholinephosphotransferase in aged rats. Neurosci Lett 2001;299:209–212
   PubMed Web of Science ®Google Scholar
• Antonopoulou S, Demopoulos CA, Iatrou C, et al. Platelet activating factor acetylhydrolase (PAF-AH) in human kidney. Int J Biochem 1994;26:1157–1162
   PubMedGoogle Scholar
• Congdon N, O'Colmain B, Klaver CC, et al.; Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004;122:477–485
   PubMed Web of Science ®Google Scholar
• Krishnadev N, Meleth AD, Chew EY. Nutritional supplements for age-related macular degeneration. Curr Opin Ophthalmol 2010;21:184–189
   PubMed Web of Science ®Google Scholar
• Ma L, Dou HL, Wu YQ, et al. Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis. Br J Nutr 2011;8:1–10
   Google Scholar
• Snodderly DM. Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr 1995;62:1448–1461
   PubMed Web of Science ®Google Scholar
• Tan JS, Wang JJ, Flood V, et al. Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye study. Ophthalmology 2008;115:334–341
   PubMed Web of Science ®Google Scholar
• Seddon JM, Ajani UA, Sperduto RD, et al.; Eye Disease Case-Control Study Group. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. J Am Med Assoc 1994;272:1413–1420
   PubMed Web of Science ®Google Scholar
• Pratt S. Dietary prevention of age-related macular degeneration. J Am Optom Assoc 1999;70:39–47
   PubMedGoogle Scholar
• Age-Related Eye Disease study research group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta-carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol 2001;119:1417–1436
   PubMed Web of Science ®Google Scholar
• Tsoupras AB, Iatrou C, Frangia C, Demopoulos CA. The implication of platelet activating factor in cancer growth and metastasis: potent beneficial role of PAF-inhibitors and antioxidants. Infect Disord Drug Targets 2009;9:390–399
   PubMedGoogle Scholar
• Gomes RN, Bozza FA, Amâncio RT, et al. Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis. Shock 2006;26:41–49
   PubMed Web of Science ®Google Scholar
• Tsoupras AB, Chini M, Tsogas N, et al. In vitro anti-inflammatory and anti-coagulant effects of antibiotics towards platelet activating factor and thrombin. J Inflamm 2011;8:17
   Google Scholar
• Heuer O. Involvement of platelet-activating factor (PAF) in septic shock and priming as indicated by the effect of hetrazepinoic PAF antagonists. Lipids 1991;12:1369–1373
   Google Scholar
• Fletcher JR, DiSimone AG, Earnest MA. Platelet activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endotoxemia. Ann Surg 1990;211:312–316
   PubMed Web of Science ®Google Scholar
• Izquierdo I, Merlos M, García-Rafanel Jl. Rupatadine: a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. A review of pharmacological profile and clinical management of allergic rhinitis. Drugs Today 2003;39:451–468
   PubMed Web of Science ®Google Scholar
• Fragopoulou E, Nomikos T, Antonopoulou S, et al. Separation of biologically active lipids from red wine. J Agric Food Chem 2000;48:1234–1238
   PubMed Web of Science ®Google Scholar
• Antonopoulou S, Demopoulos CA. On the Mediterranean diet. INFORM 1997;8:776–777
   Google Scholar